LFCR
Lifecore Biomedical Inc.
6.50$
-1.1%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -7.6% | +23.0% | -15.4% | +48.5% | -34.8% | +31.8% | +8.0% | +3.7% | -14.6% | -25.4% | +47.3% | – | |
| – | +21.2% | -7.3% | -15.3% | +20.5% | -6.3% | +11.2% | +17.8% | -11.2% | +3.8% | -19.7% | +17.9% | – | |
| – | -68.1% | +265.0% | -15.5% | +105.3% | -68.8% | +105.8% | -11.2% | +42.0% | -44.3% | -42.7% | +170.6% | – | |
| – | -3.9% | -2.2% | +24.3% | -17.1% | +1.2% | -12.0% | +6.3% | +2.8% | -6.7% | -38.0% | +26.3% | – | |
| – | -16.1% | +1.5% | +25.0% | +4.6% | +17.0% | -22.3% | -9.2% | -11.0% | -0.9% | -11.0% | +0.7% | – | |
| – | +119.8% | -4.6% | -69.5% | +56.7% | +12.2% | -23.1% | +44.7% | -54.1% | +25.5% | -15.9% | +4.1% | – | |
| – | – | – | – | – | -639.0% | – | – | – | -157.6% | – | – | – | |
| – | -18.5% | +3.4% | -3.4% | +47.2% | -7.3% | +1.8% | +0.3% | +0.7% | +15.6% | +15.1% | +5.5% | – | |
| – | – | – | -306.6% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -124.8% | – | – | -118.6% | – | +909.1% | -87.1% | -46.5% | – | |
| – | – | – | -350.2% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -1,089.3% | – | -836.0% | – | -212.7% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.